A groundbreaking trial has confirmed that inclisiran significantly reduces low-density lipoprotein cholesterol (LDL-C) levels in patients at high and very high risk of cardiovascular events. The...
A recent study reveals that a simple cheek-swab test can identify children at risk of a potentially deadly heart condition known as arrhythmogenic cardiomyopathy (ACM) up...
